Mice with NASH show a significant reduction in Mfn2; in addition, the re-expression of Mfn2 improved the disease, thus suggesting that regulating the expression levels of Mfn2 in the liver of NASH might potentially serve as a therapeutic target for male reproductive function [159]. Here, MFN2 is linked to metabolic dysfunction-associated steatohepatitis.